Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Status:
Active, not recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether it is feasible to give a combination of
Metformin and omega-3 fatty acids for one year to women with a history of early stage breast
cancer. We will also evaluate whether the metformin and omega-3 fatty acids combination
causes changes in breast tissue, blood, and mammograms.